Skip to content

Clinical Study of the Safety of a Single-port Endoscopic Surgical System for General Surgery

Clinical Study of the Safety of a Single-port Endoscopic Surgical System for General Surgery: An Exploratory Study of a Novel Robotic System

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05486299
Enrollment
10
Registered
2022-08-03
Start date
2022-03-07
Completion date
2023-03-31
Last updated
2022-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Surgery

Keywords

robotic surgery, robotic assisted single-incision surgery

Brief summary

This is a small-scale pre-clinical exploratory study to investigate the safety of a novel single-port robotic system for general surgery.

Detailed description

Single-incision laparoscopic surgery is a surgical procedure in which multiple laparoscopic instruments are placed through a single small incision. It has the advantages of less surgical trauma, better cosmetic results and less postoperative pain compared with conventional laparoscopic surgery. However, the technical challenges and difficulties, including loss of triangulation, parallel coaxial effect, difficulty of achieving correct exposure, shared fulcrum, lack of ergonomic favorable position, etc. limited its widespread use. Robot-assisted laparoscopic surgery have significant advantages such as minimally invasive, delicate, and flexible, which can greatly expand the surgeon's surgical capabilities and effectively solve the various problems faced by traditional surgery. Therefore, robotic assisted single-port surgery is attracting increasing attention. This study is to investigate the safety of a novel single-port robotic system for general surgery.

Interventions

PROCEDURERobotic assisted single-port general surgery

Robot assisted single-port rectal resection, colectomy, partial gastrectomy, appendectomy and cholecystectomy via the single-port configuration

Sponsors

Ruijin Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* 18 years \< age ≤75 years * Suitable for minimally invasive surgery * 18.5≤BMI≤28 kg/m2 * ASA score is Ⅰ-Ⅲ * Informed consent * Colon and rectal resection: colon and rectal polyps, inflammatory bowel disease, intestinal diverticula, colorectal cancer diagnosed cT3N0M0 with a maximum diameter of ≤4 cm located above the peritoneal reflection. * Partial gastrectomy: gastric stromal tumor, gastric giant ulcer. * Appendectomy: chronic appendicitis. * Cholecystectomy: chronic cholecystitis combined with gallbladder stones, gallbladder polyps (\> 1 cm).

Exclusion criteria

* With other malignancies or a previous history of other malignancies * Undergone other major surgical treatment within 3 months prior to enrolment or planned during the trial * With active tuberculosis * With severe systemic disease * With long-term use of anticoagulant and anti-platelet drugs (anti-platelet aggregation drugs discontinued less than 1 week prior to surgery), history of bleeding disorders or hematopoietic or coagulation disorders. * With severe allergies and suspected or established alcohol, drug or substance addiction * Patients who are immunodeficiency virus (HIV) antibody positive; hepatitis B surface antigen (HbsAg) positive and have a hepatitis B virus DNA (HBV-DNA) copy number above the lower limit of detection or normal range; hepatitis C virus (HCV) antibody positive; syphilis spirochete antibody positive and at high risk of transmission as judged by the investigator. * Emergency surgery * Women who are pregnant, breastfeeding or planning to become pregnant during the trial * Other conditions which, in the opinion of the investigator, make participation in this trial inappropriate.

Design outcomes

Primary

MeasureTime frameDescription
Conversion rateintraoperativeThe proportion of converted to laparotomy, laparoscopic surgery and added ≥ 2 trocars

Secondary

MeasureTime frameDescription
Operative timeintraoperativeOperative time(minutes)
Intraoperative blood lossintraoperativeEstimated blood loss(milliliters,ml)
Length of stay1-14 days after surgeryThe postoperative day when patients complied with the predefined discharge criteria(days after surgery)
Early morbidity rate30 days after surgerymorbidity rate 30 days after surgery
Incision healing1-14 days after surgeryIncision healing grade at discharge. Grade A: well healed; Grade B: incision with inflammatory reaction but no suppuration; Grade C: incision cracked and suppurating

Countries

China

Contacts

Primary ContactRen Zhao, MD, PHD
zhaorensurgeon@aliyun.com+8618917762018
Backup ContactKun Liu, MD
lookiere@126.com+8618121263082

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026